These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19203292)

  • 1. Covalent modifiers: an orthogonal approach to drug design.
    Potashman MH; Duggan ME
    J Med Chem; 2009 Mar; 52(5):1231-46. PubMed ID: 19203292
    [No Abstract]   [Full Text] [Related]  

  • 2. How well can fragments explore accessed chemical space? A case study from heat shock protein 90.
    Roughley SD; Hubbard RE
    J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of biomolecular interactions with complex-binding small molecules.
    Cai Z; Greene MI; Berezov A
    Methods; 2008 Sep; 46(1):39-46. PubMed ID: 18571508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
    Macdougall IJ; Griffith R
    J Mol Graph Model; 2008 Apr; 26(7):1113-24. PubMed ID: 18023378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-gamma activators.
    Sharon A; Pratap R; Vatsyayan R; Maulik PR; Roy U; Goel A; Ram VJ
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3356-60. PubMed ID: 15953723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
    Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
    J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
    Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of 7-carbamate analogs of geldanamycin.
    Rastelli G; Tian ZQ; Wang Z; Myles D; Liu Y
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5016-21. PubMed ID: 16165354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and local anesthetic activity--lipophilicity relationships for a homological series of phenylcarbamic acid esters. Note II.
    Gregán F; Svec P; Kettmann V; Sivý J
    Farmaco; 1996 Oct; 51(10):669-72. PubMed ID: 8981758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based development of target-specific compound libraries.
    Orry AJ; Abagyan RA; Cavasotto CN
    Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.
    Li JJ; Iula DM; Nguyen MN; Hu LY; Dettling D; Johnson TR; Du DY; Shanmugasundaram V; Van Camp JA; Wang Z; Harter WG; Yue WS; Boys ML; Wade KJ; Drummond EM; Samas BM; Lefker BA; Hoge GS; Lovdahl MJ; Asbill J; Carroll M; Meade MA; Ciotti SM; Krieger-Burke T
    J Med Chem; 2008 Nov; 51(21):7010-4. PubMed ID: 18921992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology-based modelling of targets for rational drug design.
    Wieman H; Tøndel K; Anderssen E; Drabløs F
    Mini Rev Med Chem; 2004 Sep; 4(7):793-804. PubMed ID: 15379646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.